DrugPatentWatch Database Preview

Degarelix acetate - Generic Drug Details

  Purchase this report

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for degarelix acetate and what is the scope of degarelix acetate freedom to operate?

Degarelix acetate is the generic ingredient in one branded drug marketed by Ferring and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for degarelix acetate

US Patents:	3
Tradenames:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	23
Clinical Trials:	20
Patent Applications:	11
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for degarelix acetate
DailyMed Link:	degarelix acetate at DailyMed

Synonyms for degarelix acetate

214766-78-6

766D786

934016-19-0

934246-14-7

Ac-D-Nal-[D-(pCl)Phe]-D-Pal-Ser-[Aph(DHor)]-D-[Aph(Cbm)]-Leu-ILys-Pro-DAla-NH2

Acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide

AKOS030526717

AN-5181

ASP-3550

ASP3550

BDBM50102450

CHEBI:135961

CHEMBL2028987

CHEMBL415606

CS-5350

D-Alaninamide, N-acetyl-3-(naphtalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-4-((((4S)-2,6-dioxohexahydropyrimidin-4-yl)carbonyl)amino)-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-leucy

D01WYT

D08635

D08901

D09400

D0Y7KH

DB06699

Degarelix

Degarelix (INN/USAN)

Degarelix [USAN:INN:BAN]

Degarelix acetate (JAN)

Degarelix acetate (USAN)

Degarelix acetate hydrate

Degarelix monoacetate

EXT215F4ZU

FE 200486

FE-200486

FE-200486 (free base)

FE200486

FE200486 (AS ACETATE SALT)

Firmagon

Firmagon (TN)

Gonax

GTPL5585

HSDB 7817

HY-16168A

N-Acetyl-3-(naphtalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-4-((((4S)-2,6-dioxohexahydropyrimidin-4-yl)carbonyl)amino)-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-leucyl-N(sup 6)-(1-m

QC-10170

RL02641

SCHEMBL1397034

SX0XJI3A11

Uglypeptide1

UNII-EXT215F4ZU

UNII-SX0XJI3A11

Z-3147

US Patents and Regulatory Information for degarelix acetate

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ferring	FIRMAGON	degarelix acetate	POWDER;SUBCUTANEOUS	022201-002	Dec 24, 2008		RX	Yes	Yes
Ferring	FIRMAGON	degarelix acetate	POWDER;SUBCUTANEOUS	022201-001	Dec 24, 2008		RX	Yes	No
Ferring	FIRMAGON	degarelix acetate	POWDER;SUBCUTANEOUS	022201-002	Dec 24, 2008		RX	Yes	Yes			Y	Y
Ferring	FIRMAGON	degarelix acetate	POWDER;SUBCUTANEOUS	022201-001	Dec 24, 2008		RX	Yes	No
Ferring	FIRMAGON	degarelix acetate	POWDER;SUBCUTANEOUS	022201-002	Dec 24, 2008		RX	Yes	Yes
Ferring	FIRMAGON	degarelix acetate	POWDER;SUBCUTANEOUS	022201-001	Dec 24, 2008		RX	Yes	No			Y	Y

  Purchase this report

see a sample report or, see our see our flat-rate plans

  Purchase this report

see a sample report or, see our see our flat-rate plans

International Patents for degarelix acetate

Country	Document Number	Estimated Expiration
European Patent Office	2249858
South Korea	20100126362
South Korea	20150091543
Hong Kong	1190912
European Patent Office	2799085
Czech Republic	9903586

Supplementary Protection Certificates for degarelix acetate

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1003774/01	Switzerland		PRODUCT NAME: DEGARELIX; REGISTRATION NUMBER/DATE: SWISSMEDIC 59455 12.02.2010
2009000033	Germany		PRODUCT NAME: DEGARELIX, GGF. IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES DAVON, WIE DEM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001-002 20090217
0395	Netherlands		300395, 20180413, EXPIRES: 20230412
585	Luxembourg		PRODUCT NAME: DEGARELIX, EVENTUELLEMENT UN SEL PHARMACEUTIQUEMENT ACCEPTABE, TEL QUE L'ACETATE (FIRMAGON); REG. DATE: 20090217
C020/2009	Ireland		SPC020/2009: 20091119, EXPIRES: 20230412
2009005	Lithuania		PRODUCT NAME: DEGARELIXUM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001, 2009 02 17 EU/1/08/504/002 20090217